Does the Age of Sudden Cardiac Death in Family Members Matter in Brugada Syndrome?

Pattara Rattanawong1,2, Jakrin Kewcharoen3, Chanavuth Kanitsoraphan3

  • 1Department of Cardiovascular Medicine Mayo Clinic Phoenix AZ.

Insights

A family history of sudden cardiac death (SCD) in Brugada syndrome patients does not increase major arrhythmic event (MAE) risk overall. However, SCD in family members under 40 significantly elevates MAE risk.

Area of Science:

  • Cardiology
  • Genetics
  • Epidemiology

Background:

  • Brugada syndrome is an inherited cardiac channelopathy linked to major arrhythmic events (MAEs).
  • The role of a family history of sudden cardiac death (SCD) as a risk predictor for MAEs in Brugada syndrome patients is debated.
  • Identifying accurate risk predictors is crucial for managing Brugada syndrome and preventing life-threatening arrhythmias.

Purpose of the Study:

  • To systematically review and meta-analyze the association between family history of SCD and MAEs in Brugada syndrome.
  • To investigate if the age of SCD in family members modifies the risk of MAEs.
  • To provide evidence-based insights into risk stratification for Brugada syndrome patients.

Main Methods:

  • Systematic review and meta-analysis of studies published between January 1992 and January 2020.
  • Searched MEDLINE and EMBASE databases for relevant research.
  • Combined data using random-effects models and performed metaregression to assess age-related risk.

Main Results:

  • Twenty-two studies involving 3386 Brugada syndrome patients were included.
  • Overall family history of SCD was not significantly associated with increased MAE risk (OR, 1.11; P=0.489).
  • A history of SCD in family members younger than 40 years approximately doubled the risk of MAEs (OR, 2.03; P=0.022).

Conclusions:

  • A family history of SCD is not a universal risk factor for MAEs in Brugada syndrome.
  • However, SCD in younger family members (specifically under 40 years) is a significant risk factor for MAEs.
  • Age stratification of SCD in family history is critical for accurate risk assessment in Brugada syndrome.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
113
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
665
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
135
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
105
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
176
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
114